1. Home
  2. DDC vs GNPX Comparison

DDC vs GNPX Comparison

Compare DDC & GNPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DDC
  • GNPX
  • Stock Information
  • Founded
  • DDC 2012
  • GNPX 2009
  • Country
  • DDC Hong Kong
  • GNPX United States
  • Employees
  • DDC N/A
  • GNPX N/A
  • Industry
  • DDC Metal Mining
  • GNPX Biotechnology: Pharmaceutical Preparations
  • Sector
  • DDC Basic Materials
  • GNPX Health Care
  • Exchange
  • DDC Nasdaq
  • GNPX Nasdaq
  • Market Cap
  • DDC 6.9M
  • GNPX 6.1M
  • IPO Year
  • DDC 2023
  • GNPX 2018
  • Fundamental
  • Price
  • DDC $0.17
  • GNPX $0.75
  • Analyst Decision
  • DDC Strong Buy
  • GNPX Strong Buy
  • Analyst Count
  • DDC 2
  • GNPX 1
  • Target Price
  • DDC $5.50
  • GNPX $10.00
  • AVG Volume (30 Days)
  • DDC 873.4K
  • GNPX 367.1K
  • Earning Date
  • DDC 09-06-2017
  • GNPX 11-13-2024
  • Dividend Yield
  • DDC N/A
  • GNPX N/A
  • EPS Growth
  • DDC N/A
  • GNPX N/A
  • EPS
  • DDC N/A
  • GNPX N/A
  • Revenue
  • DDC $32,882,772.00
  • GNPX N/A
  • Revenue This Year
  • DDC N/A
  • GNPX N/A
  • Revenue Next Year
  • DDC N/A
  • GNPX N/A
  • P/E Ratio
  • DDC N/A
  • GNPX N/A
  • Revenue Growth
  • DDC 18.16
  • GNPX N/A
  • 52 Week Low
  • DDC $0.12
  • GNPX $0.28
  • 52 Week High
  • DDC $3.34
  • GNPX $13.00
  • Technical
  • Relative Strength Index (RSI)
  • DDC 45.91
  • GNPX 40.74
  • Support Level
  • DDC $0.15
  • GNPX $0.66
  • Resistance Level
  • DDC $0.20
  • GNPX $0.74
  • Average True Range (ATR)
  • DDC 0.03
  • GNPX 0.06
  • MACD
  • DDC 0.00
  • GNPX 0.00
  • Stochastic Oscillator
  • DDC 17.44
  • GNPX 35.04

About DDC DDC Enterprise Limited

DDC Enterprise Ltd is a content driven consumer brand offering easy, convenient ready-to-heat , ready-to-cook and plant-based meal products i.e. meal products consisting largely or solely of vegetables, fruits, grains and other foods derived from plant-based protein, rather than animal protein) while promoting healthier lifestyle choices to Millennial and Generation Z customer-base. It is also engaged in the provision of advertising services and the operation of experience stores to offer cooking classes.

About GNPX Genprex Inc.

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's lead product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.

Share on Social Networks: